|
HS Code |
461247 |
As an accredited 2-(4-Bromophenyl)Benzimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-(4-Bromophenyl)Benzimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Some products capture attention for their remarkable versatility. 2-(4-Bromophenyl)Benzimidazole is one of those. In my lab days, I often spotted compounds promising streamlined workflow or improved yield, but after digging into this molecule, its utility feels worth sharing up front. The model represented here is defined by the chemical structure itself: a benzimidazole backbone bonded with a 4-bromophenyl group. This pairing sounds technical, but the implications reach beyond academic curiosity.
The precise formula, C13H9BrN2, places this compound among the halogenated benzimidazoles, setting it apart from simple benzimidazole. The bromine atom isn’t just decoration; it matters for both reactivity and downstream applications. The melty white-to-off-white powder looks nondescript sitting in a jar, but its profile brings several advantages to chemical synthesis, pharmaceutical development, and material science. Reflecting on my benchmarks for specialty chemicals, compounds rarely combine reactivity and stability in a single package. Here, 2-(4-Bromophenyl)Benzimidazole stands out for its chemical reliability during reactions, a trait usually making or breaking a project’s flow in organic synthesis.
Taking a practical approach, I think of this compound as a bridge—not just a starting material, but a stepping stone. In pharmaceutical labs, researchers often need benzimidazole derivatives for testing new bioactivities, since benzimidazole rings pop up in many marketed therapeutics. Add a 4-bromophenyl group, and you open doors to further substitutions through Suzuki or Buchwald–Hartwig couplings. It might sound dry, but this reactivity saves time, expands options, and enables access to unique analogs that plain benzimidazoles don’t cover. Years ago, I watched colleagues struggle with less reactive halogen groups; bromine hits the right note for cross-coupling—not too sluggish, not too jumpy.
On the material science side, benzimidazole-based structures fill needs in organic electronics and dye-sensitized applications. Picture an OLED researcher looking for fine-tuned hole-transport layers—adding brominated phenyl rings can tweak electronic properties and processibility. From experience, one can spend weeks sifting through candidates that just don’t perform under scale-up or thermal stress. This compound’s aromatic system and reliable melting point let scientists scale up without blowing the budget on safety or waste disposal. With a melting point typically around 246-250 °C, stability concerns rarely hold back progress.
Why pick 2-(4-Bromophenyl)Benzimidazole over close cousins? Structural details drive the choice. Some might default to chlorinated or fluorinated benzimidazoles, but real-world applications tend to favor bromine's balance of leaving-group potential and manageable toxicity. In multi-step syntheses, time and yield can vanish if your halogen doesn’t behave. I recall colleagues lamenting the limitations of chlorinated variants—sluggish reactions, rough purifications, persistent byproduct headaches.
Brominated phenyl benzimidazole walks the line between functionality and process efficiency. Halogen exchange tends to work best with bromine, offering room for further elaboration without the headaches chlorine or iodine introduce. Comparing the options, 2-(4-Bromophenyl)Benzimidazole offers a good handshake between ease of handling and chemical versatility. As someone who ran extractions and purifications for weeks, little things like solubility and crystallization make or break a research schedule. This compound handles routine solvents—dichloromethane, ethanol, or even acetonitrile—without demanding special procedures. That’s a reputation earned after seeing too many promising intermediates dissolved away by aggressive acids or sticking to filtration glassware.
Think of the main ways researchers reach for this compound. Synthetic chemists often introduce it as an intermediate for pharmaceutical research. Medicinal chemistry teams appreciate how it paves the way to libraries of more complex molecules. The 4-bromophenyl handle makes palladium-catalyzed cross-couplings straightforward—no guessing at reactivity trends or sweating activation steps. I learned the hard way never to discount how much a good leaving group can speed up hit-to-lead campaigns in drug design.
Beyond drug discovery, its footprint stretches to pigment synthesis and polymer modification, riding on the chemical stability conferred by the benzimidazole core. In my time handling polyaromatic intermediates, I prized anything that stuck together under light, oxygen, and mild base. This compound behaves itself, reducing lost yield from degradation or side reactions—those operations add up in both academic and industrial labs.
Material scientists look to this molecule as a custom-building block. The benzimidazole ring’s planarity and electron-rich character impart desired strength and electronic tuning to new organic materials. For nascent electronics and photovoltaics, it often becomes part of the “spine” in polymer repeat units, influencing color bands or conductive pathways. In practice, batches containing 2-(4-Bromophenyl)Benzimidazole often exhibit greater consistency and reproducibility—traits that spill over to lower costs during scale-up and device prototyping.
Among benzimidazole derivatives, differences can seem subtle on paper but translate to real gains at the bench. The bromine atom makes a key difference. Against the fluoro or chloro variants, brominated compounds tend to substitute more easily under palladium and copper conditions, which speeds up cycles between idea and reality. I watched projects stall out while waiting for purification of trickier halides; this version gets the job done with less troubleshooting.
Simple benzimidazole lacks reactive handles, so functional group installation calls for extra steps—time-consuming and inefficient under pressure to deliver results. By building from 2-(4-Bromophenyl)Benzimidazole, chemists sidestep those detours and focus on pushing boundaries rather than solving old problems. While iodine can substitute faster, it raises problems around cost, toxicity, and supply stability. In years past, I saw groups forced to drop iodine-bearing intermediates because the sourcing or handling risks turned prohibitive. Bromine’s middle ground—affordable, accessible, less hazardous—ends up more attractive.
Looking at physical attributes, each benzimidazole derivative has specific solubility and melting characteristics. This compound handles itself without fuss in standard solvents, unlike some analogs that demand rare earths or custom mixtures. Over many projects, colleagues valued reliability above novelty; specialty chemicals that play by the rules, batch after batch, earn trust. 2-(4-Bromophenyl)Benzimidazole slots in there by consistently matching performance spec, whether in grams or kilograms.
2-(4-Bromophenyl)Benzimidazole weighs in at 273.13 g/mol, a detail that guides dosing in reactions and quantification by NMR or LC-MS. The powder appearance is dry, typically pale off-white, and remains free-flowing unless exposed to excessive humidity. Standard purity sits near or above 98% for most lab shipments, verified by HPLC or melting point ranges. The melting point—usually right around the 246-250 °C mark—reflects solid-state purity and provides a check for unwanted impurities. I wouldn’t recommend sweating precise melting data unless your project depends on semi-conductor grades, but anybody running multistep synthesis should keep an eye fixed on thermal transitions.
Stability under ambient conditions marks another tick in the plus column. While some halogenated aromatics degrade quickly, this compound stores well at room temperature provided it stays dry and in dark glass. I never saw substantial loss of integrity over several months, critical when research spans quarters rather than weeks. Some colleagues store it cold for extra assurance, but out of all the benzimidazoles I’ve handled, this one requires less babying than most.
Spectroscopy data, IR, and NMR fingerprints line up cleanly. Typical ‘H’ NMR profiles show the aromatic protons in expected regions, while bromine does not confuse spectra with unwanted minor peaks or side-products. Peaks stay sharp unless the product’s been heavily contaminated, aiding fast purity checks for busy labs. IR signals confirm substitution on the phenyl ring without masking the benzimidazole core, a fact appreciated during troubleshooting sessions.
In any research setting, time and reliability carry more weight than hype. 2-(4-Bromophenyl)Benzimidazole brings both. Material scientists appreciate the predictable reactivity, while synthetic chemists turn to it for flexible late-stage functionalization. In pharmaceutical campaigns, I’ve seen this compound speed up analog synthesis—not only by enabling faster bond formation, but by cutting back on wasted steps and troubleshooting.
Handling requirements for this powder don’t go overboard: gloves, goggles, and reasonable ventilation keep risks manageable. The material doesn’t combust easily or give off volatile organics at room temperature, which lowers the stress of daily benchwork. Some more reactive benzimidazoles demand inert gases or elaborate containment; that isn’t the case here. Safety records back this up. Similar compounds have been evaluated for environmental fate and persistence. Brominated aromatics raise questions about downstream metabolites, yet this compound’s modest scale of use and manageable toxicity land better than many alternatives on risk assessments.
For those in scale-up or pilot operations, waste streams matter. The byproducts generated during coupling chemistry or cross-linking tend not to include persistent pollutants—at least, not to the degree seen in polyfluorinated or polyiodinated analogs. If I were betting on adoption curves, I’d put chips here for wide compatibility with “green” or solvent-minimizing procedures. Newer, more sustainable synthetic routes increasingly favor compounds like this over less tractable options.
Every chemical faces trade-offs. While 2-(4-Bromophenyl)Benzimidazole solves many bottlenecks, scale always plays a part in uptake. Its cost sits moderate compared to basic benzimidazoles, mostly due to the halogen source and downstream processing. In periods of bromine price volatility, production costs can tick upward, though rarely to dealbreaking levels for research quantities. For large-scale industrial applications, procurement teams weigh these small differences—years ago, I saw how these compound-by-compound spreadsheet comparisons impact the final decision.
Toxicity and environmental effect remain under watch. Brominated aromatics must be disposed of responsibly; nobody wants to invite regulatory scrutiny over poor waste management practices. In my experience, compliance relies on transparency with disposal vendors and careful logging—not always the glamorous side of R&D, but crucial for staying ahead of audits and minimizing legacy contamination. Newer in-lab protocols prefer combinations with solvent-recycling and closed-loop filtration, both reducing the impact and easing paperwork headaches.
Another consideration, especially for educational and small-company settings, is training. Teams lacking familiarity with cross-coupling palladium chemistry or aromatic handling can hit roadblocks if they skip foundational prep. I noticed junior chemists tripping up over dried solvents or unprotected glassware, making for avoidable delays and inconsistent results. Training in reaction setup, quenching, and post-reaction handling goes a long way to unlocking the full value of compounds like this one.
Bridging gaps between specialty chemicals and mainstream adoption comes down to a blend of education, responsible sourcing, and smart handling. The marketplace keeps shifting toward greener standards—institutes and companies now look harder at lifecycle impacts, waste minimization, and supply chain transparency. Seeing these changes personally, I believe products with reliable production records and a clean handling profile, like 2-(4-Bromophenyl)Benzimidazole, will increasingly move into favored positions.
Suppliers able to openly share third-party analytic data, including purity, melting point, and common impurity profiles, build trust. I’ve noticed purchasing departments shifting toward vendors supporting transparent specifications—no surprises, no hidden formulation tweaks between batches. Ongoing education builds confidence among team members, too. Workshops, webinars, and onboarding sessions focused on cross-coupling, waste segregation, and solvent handling extend beyond compliance—they make everyone’s life easier and research more productive.
Material innovators get the biggest boost from reliable, single-component intermediates that work across projects. Every new device or drug candidate pushes the boundaries of what’s known, and few things kill momentum quicker than inconsistent input chemicals. In my own projects, trusted intermediates like this keep project teams on track, supporting iterative design without repeats or costly retesting. Streamlined procurement and well-written safety sheets shore up this trust, giving peace of mind to bench chemists and process engineers alike.
Stepping back, the case for 2-(4-Bromophenyl)Benzimidazole rests on a proven blend of structure and practicality. The benzimidazole core and brominated phenyl group combine in ways that serve both synthetic chemistry and advanced material science. Researchers, process chemists, and innovators looking to solve real problems have every reason to keep this compound in mind. From routine cross-couplings to ambitious device fabrication, its consistent performance, balanced reactivity, and approachable safety footprint put it a step ahead of many close analogs. Backed by solid hands-on chemistry and a marketplace shifting toward reliability and transparency, it marks a smart choice for those demanding more from their reagents and building blocks.